Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) EBT (2016 - 2025)

Xtant Medical Holdings has reported EBT over the past 16 years, most recently at $1.6 million for Q4 2025.

  • Quarterly EBT rose 150.83% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, up 143.05% year-over-year, with the annual reading at $7.0 million for FY2025, 143.05% up from the prior year.
  • EBT was $1.6 million for Q4 2025 at Xtant Medical Holdings, up from $1.6 million in the prior quarter.
  • Over five years, EBT peaked at $6.9 million in Q3 2023 and troughed at -$5.0 million in Q3 2024.
  • The 5-year median for EBT is -$2.1 million (2023), against an average of -$1.2 million.
  • Year-over-year, EBT tumbled 36400.0% in 2022 and then skyrocketed 396.2% in 2023.
  • A 5-year view of EBT shows it stood at -$2.4 million in 2021, then increased by 7.95% to -$2.2 million in 2022, then crashed by 70.29% to -$3.7 million in 2023, then grew by 15.62% to -$3.1 million in 2024, then surged by 150.83% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's EBT are $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $3.8 million (Q2 2025).